Molecular screening for colon cancer detection

Digestive and Liver Disease

Volumn 32, Issue 2, 2000, Pages 173-177

  Villa, E ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Colorectal cancer; Faecal occult blood test

Indexed keywords

CYTOKERATIN 20; PROTEIN KINASE C; PROTEIN P53;

ADENOMATOUS POLYP; ARTICLE; CANCER RISK; CANCER SCREENING; COLON POLYPOSIS; COLORECTAL CANCER; FAMILIAL CANCER; GENE MUTATION; GENE TARGETING; HUMAN; OCCULT BLOOD TEST; ONCOGENE K RAS;

EID: 0034010346     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1590-8658(00)80405-3     Document Type: Article

References (30)

1. Norum J. Prevention of colorectal cancer: a cost-effectiveness approach to a screening model employing sigmoidoscopy. Ann Oncol 1998;9:613-8.
2. Winawer SJ, Andrews MNA, Flehinger B, Sherlock P, Schottenfeld D, Miller DG. Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia. Cancer 1980;45:2959-64.
3. Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasms: sensitivity, specificity and predictive value. Long-term follow-up in a large groups practice setting. Ann Intern Med 1990;112:328-33.
4. Thomas WM, Hardcastle JD. An update on the Nottingham trial of faecal occult blood screening for colorectal carcinoma. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC, editors. Cancer screening. Cambridge, UK: Cambridge University Press; 1991. p. 106-15.
5. Kewenter J, Asztely M, Engaras B, Haglind E, Svanvik J, Ahren C. A randomised trial of fecal occult blood testing for early detection of colorectal cancer: result of screening and rescreening of 51,325 subjects. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC, editors. Cancer screening. Cambridge, UK: Cambridge University Press; 1991. p. 116-25.
6. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, et al. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and Hemoquant tests. J Am Med Assoc 1993;269:1262-7.
7. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer: is mortality reduced by chance selection for screening colonoscopy? J Am Med Assoc 1994;271:1011-3.
8. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
9. Kronborg O. Screening for colorectal neoplasia. Ital J Gastroenterol Hepatol 1999;31:127-9.
10. Delcò F, Sonnenberg A. Limitations for the faecal occult blood test in screening for colorectal cancer. Ital J Gastroenterol Hepatol 1999;31:119-26.
11. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
12. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, de Costa LT, Rozenblum E, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-3.
13. Hemminki A, Marke D, Tomlison I, Avizienyte E, Roth S, Loukola A, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998;391:184-7.
14. Aaltonen LA, Peltomaki P, Mecklin JP, Jarvinen H, Jass JR, Green JS, et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994;54:1645-8.
15. Aaltonen LA, Peltomaki C, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
16. Huang J, Papadopoulos N, McKinley AJ, Ferrington SM, Curtis LJ, Wyllie AH, et al. APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci USA 1996;93:9049-54.
17. Redstone MS, Papadopoulos N, Caldas C, Kinzler KW, Kern SE. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology 1995;108:383-92.
18. Whitby LG. Screening for disease. Definitions and criteria. Lancet 1974;2:819-22.
19. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992;256:102-4.
20. Wallis YL, Morton DG, McKeown CM, Maconald F. Molecular analysis of the APC gene in 205 families, extended genotype-phenotype correlation in FAP and evidence for the role of APC amino acid change in colorectal cancer predisposition. J Med Gen 1999;366:14-20.
21. Powell SM, Petersen GM, Krush AJ, Booker S, Jen J, Giardiello FM, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993;329:1982-7.
22. Tominaga O, Nita ME, Nagawa H, Muto T. Screening for APC mutations bases on truncated APC proteins. Dig Dis Sci 1998;43:306-10.
23. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998;338:1481-7.
24. Smith-Ravin J, England J, Talbot IC, Bodmer W. Detection of c-Ki-ras mutations in fecal samples from sporadic colorectal cancer patients. Gut 1995;36:81-6.
25. Tobi M, Luo F-C, Ronai Z. Detection of K-ras mutation in colonie effluent samples from patients without evidence of colorectal carcinoma. J Natl Cancer Inst 1994;86:1007-10.
26. Hasegawa Y, Takeda S, Ichii S, Koizumi K, Maruyama M, Fujii A, et al. Detection of K-ras mutation in DNAs isolated from feces of patients with colorectal tumors by mutation-allele-specific amplification (MASA). Oncogene 1995;10:1441-5.
27. Nollau P, Moser C, Weinland G, Wagener C. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 1996;66:332-6.
28. Villa E, Dugani A, Rebecchi AM, Vignoli A, Grottola A, Buttafoco P, et al. Identification of subjects at risk for colorectal carcinoma through a test with K-ras determination in the stool. Gastroenterology 1996;110:1346-53.
29. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987;327:298-303.
30. Eguchi S, Kohara N, Komuta K, Kanematsu T. Mutations in the p53 gene in the stool of patients with resectable colorectal cancer. Cancer 1996;77:1707-10.